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remains undetected and untreated(6). So we planned 
this study to find the magnitude and related factors of 
PSD in survivors of stroke. Early diagnosis and successful 
intervention may improve clinical outcome of PSD and 
should be considered a key for better stroke care. Early 
effective treatment of depression may have a positive 
effect not only on depressive symptoms but also on the 
rehabilitation outcome of stroke patients.
Table-1
Distribution of Post stroke depression by gender
(n=100)
Table-2
Distribution of patients according to Depression 
Level
MATERIAL & METHODS
After approval from hospital ethical review board, this 
study was planned. It was a cross-sectional survey 
conducted at department of neurology, Services 
Institute of Medical Sciences (SIMS), Services hospital, 
Lahore over a period of one year, from January, 2014 to 
December, 2014. A sample size of 100 cases was 
calculated with 95% confidence level, 9.5% margin of 
error and taking expected percentage of depression i.e. 
34% after 1 month in post stroke patient(7). All the 
patients with stroke (confirmed by CT scan) presenting 
in out patient department, minimum after one month of 
the event, above 40 years of age were included in the 
study. Those having subarachnoid hemorrhage and 
venous etiology of stroke on CT scan brain, having 
history of death of spouse within 6 month duration and 
previous history of stroke were excluded from the study 
as all these factors are proven as isolated risk factors in 
different studies. These patients were evaluated for 
presence or absence of depression by researcher 
himself. A questionnaire was used as a data collection 
tool and score was given using Personal Health 
Questionnaire (PHQ-9) on the basis of diagnostic and 
statistical manual fourth version (DSM-iv). The rating 
scale was shown in questionnaire incorporated in 
performa with interpretation of total score as less than 
4 as no PSD, 5-9 asmild PSD, 10-14 as moderate 
PSD, 15-19 as moderately sever PSD and 20-27 as 
sever PSD. Also age, gender, side of the brain involved 
(dominant or non-dominant) and educational status of 
the patients were evaluated. All the collected data was 
entered into SPSS (statistical package for social 
sciences) 21.0 version and was analyzed descriptively. 
In our descriptive analysis, counts and percentages 
were calculated for qualitative variables like gender, PSD 
while mean and standard deviation were calculated for 
quantitative variables like patient age etc.
RESULTS
The mean age of patients was found to be 54.8 ± 8.1 
years in our study. Out of the total 100 patients, 33 
patients (33%) were in 40-50 year age group, 46 
patients (46%) were in 51-60 years age group and the 
remaining 21 patients (21 %) were in 60 years and 
above age group.Among 100 patients, 37% (n=37) 
were male and 63% (n=63) were female. In our study 
PSD was found in 35% (n=35) of the patients. Among 
these 35 patients with PSD 23 patients (65.7%) were 
female and 12 patients (34.3%) were male. Out of total 
of 63 female patients included, PSD was present in 23 
patients (36.5%) and was absent in the remaining 40 
patients (63.5%). As far as the male patients are 
concerned, out of the total 37 patients, PSD was 
present in 12 patients (32.4%) and absent in the 
remaining 25 patients (67.6%). Mild depression was 
present in 3 female patients but no male patient was 
found with mild depression in this study. Moderate 
depression was present in 4 male and 5 female 
patients. Moderately severe depression was observed in 
3 male and 5 female patients. Severe depression was 
observed in 5 male and 10 female patients. The average 
post stroke duration was 1.97±0.8 months in patients 
with PSD while it was 2.26±1.1 months in patients 
without PSD. In 22 patients (62.8%), lesion was on the 
left side of the brain (dominant half) and 13 patients 
(37.14%) had lesion on the right side of the brain 
(non-dominant half). There were 67 (67%) illiterates, 16 
(16%) educated up to primary school, 5 (5%) educated 
up to middle school and 8 (8%) educated high school 
and above of the total 100 patients.
DISCUSSION
Stroke is a disease associated with many complications. 
PSD is one of the important complications during 
post-stroke period. Although it is an important research 
issue and lot of work is being done on this subject in 
world but a little data is available on this subject in 
Pakistan (9). In this study we found that amongst the 
patients selected for the study, 37% were male and 
63% were females. It is in accordance with the results 
presented by most of the previous authors. ZhangWN 
and colleagues also found female gender as a risk 
factor. They calculated Odds Ratio (OR) value being 
3.1483, P<0.05 (10). It may be due to the factor that 
depression and psychological disorders are also 
otherwise more common in females than males. In our 
study we found the PSD in 35% of the patients. The 
reported frequency of PSD in previous studies ranges 
from 20% to 65% (11). This wide variation in results is 
due to different criteria for patient selection, some 
earlier studies are concerned with depression after 
ischemic stroke only or both ischemic and hemorrhagic 
stroke(12). The results also depend on the time elapsed 
after stroke and difficulties in estimating depression in 
stroke patients with a cognitive or physical handicap 
also cause inaccuracies(13). Although there was 
considerable variation in the reported frequency of 
depression after stroke across individual studies. A 
meta-analysis has estimated the pooled frequency of 
PSD at 33%, even with relevant differences across 
studies(14). PSD is commonly unrecognized and 
untreated in clinical practice. According to Schubert et 
al, nonpsychiatric physicians fail to diagnose 50% to 
80% of the actually existing depression. However, PSD 
is most likely not solely a psychological reflection of a 
physical disability(15). Folstein MF and colleagues 
conducted a trial and demonstrated that stroke patients 
were significantly more commonly depressed than 
orthopedic patients with equal levels of functional 
disability (45% versus 10%) (16). In our study also we 
found that 62.8% of patients with PSD had left 
hemisphere involvement than 37.2% having right side 
involved. Our findings are consistent with findings of 
Saxena A and Suman A, who found the PSD in 68.8% 
of patients with left hemisphere involvement than 
42.9% of patients with right side involved (P=0.008) 
(17). However, Wei N and colleagues recently published 
their systematic review on this topic and they found no 
correlation between PSD and side of brain involved. 
They only found significant association between non 
dominant hemisphere stroke and incidence of 
depression for studies within sub acute post-stroke 
phase. Due to this discrepancy in literature, this 
hypothesis that lesion of the dominant hemisphere are 
associated with an increased risk of depression after 
stroke, is no longer considered true (18). The mean age of 
patients found in our study was 54.8 ± 8.1 years. In 
our study this age was higher than previous studies 
because we included patients above age of 40 years 
because in our society particularly, male members are 
bread earners and disability at younger age is found 
having more depression than older ones (19). However, 
Naess presented their report on 196 patients with 
stroke and they found that stroke patients in age group 
15–49 had lower PSD incidence than elderly patients 
(20). But some data suggest that there was no significant 
differences between various age groups (21). The conflict 
conclusion may be drawn because different group of 
patients were chosen to be studied in different centers. 
So a large study sample with multi-center involvement 
must be conducted to sort this out. Also, there is a 
great variability in the method applied and the 
diagnostic tools used for the detection of PSD. Some 
researchers used structured statements or questions 
and other follow a structured interview and the 
diagnostic standards defined by DSM (Diagnostic and 
statistical manual of mental disorders)-III, III-R, and IV, 
and some even base their assessment only on clinical 
findings. Even when most of the studies based on the 
same diagnostic tool, the diagnosis on cutoff score 
varies in different rating scales. The PHQ-9 is a brief 
diagnostic and severity measure of depression, which 
has been widely used in research and clinical 
practice(22). The PHQ-9 was successfully used for 
screening post-stroke depression patients in our study. 
Similar findings are noted in the Heart and Soul study of 
depression among patients with coronary heart 
disease(23). A meta-analysis that included chronic care 
conditions involving patients from cardiology, renal 
dialyses, brain injury and stroke facilities as well as 
general medical out patients found the PHQ-9 
acceptable as a diagnostic screening tool for major 
depression(24). In spite of the abundant literature 
available on this topic, it is still difficult to define the real 
prevalence rate of PSD, essentially because of the 
weak concordance across studies. This relevant 
variability arises not only from methodological problems 
of the investigations (differences in study populations 
and the timing of assessments) but also from the 
complexity in recognition, assessment, and diagnosis of 
depression. In our study, there were 35 patients who 
were found to have PSD and these patients were 
referred to psychiatrist for treatment. It is recommended 
for all stroke patients to be evaluated for depression and 
must be treated accordingly to reduce the morbidity, 
mortality and to improve the functional outcome of the 
patients. 
CONCLUSIONS
Post stroke depression is common in patients with 
stroke and it directly or indirectly affects both morbidity 
and mortality in these patients. So in order to improve 
outcome in these patients, all patients with stroke 
should be screened and evaluated accordingly.
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ABSTRACT
Introduction: Stroke is a common neurological problem and the third leading cause of death in developed countries 
of the world. Among survivors, over 50% develop significant disabilities including neuro-psychiatric disabilities. Post 
stroke depression (PSD) is a common but less reported condition among survivors. Objectives: To determine the 
frequency of depression in patients with stroke. Materials and methods: This was a cross-sectional study conducted 
at Department of Neurology, Services Hospital, Lahore from January, 2014 to December, 2014 over a period of 1 year. 
A total of 100 cases having stroke minimum 1 month ago, were recruited in the study. For evidence of depression, 
Personal Health Questionnaire (PHQ-9) with criteria for mild, moderate, moderately sever and severe depression was 
used. Results: Mean age of the patients was 54.8 ± 8.1 years. In our study 63% of the patients were female while 
37% patients were male. Post stroke depression was found in 35% of cases; 15% had severe depression, 8% had  
moderately severe, 9 % had moderate and only 3% patients had mild depression. Among these 35 patients, 22 
patients (62.8%)had involvement of dominant half of brain while 13 patients (37.2%) had non-dominant half involved. 
Conclusion: Post stroke depression is present in significant number of post stroke patients. So it is advised to do PSD 
evaluation of all stroke patients for early and proper management.  
KEY WORDS: Stroke; Post stroke depression; Depression.
INTRODUCTION
Stroke is a common neurological problem and the third 
leading cause of death in developed countries of the 
world.(1) According to a survey in 2010, about 11.5 
million patients suffered from ischemic strokes (63% in 
low-income and middle-income countries) and 5.3 
million patients had hemorrhagic strokes (80% in 
low-income and middle-income countries). An 
estimated 5.8 million individuals died from stroke in a 
year(2). Among survivors, over 50% have significant 
disabilities creating physical, social and psychological 
burden on themselves as well as on the family(3). 
Neuropsychological symptoms are probably among the 
most commonly ignored complications in stroke 
patients. Depression is a common yet often 
unrecognized neuropsychological consequence of 
stroke, having biological, psycho behavioral and social 
dimensions(4). Post stroke depression (PSD) is 
multifactorial in origin and develops under the influence 
of biopsychosocial factors. The anatomical correlates of 
PSD change over time. The most relevant psychosocial 
risk factors for PSD may include: past history of 
depression and other mental disorders, dysphasia, 
functional impairment, lone living style, post-stroke 
social isolation & lack of family support(5). PSD is 
prevalent in both genders, but appears to be slightly 
more common among women than men. The reported 
prevalence of depression following a stroke varies from 
20% to 50% within the first year, with an apparent peak 
within the first 6 months of onset of event(6). According 
to another study, prevalence has been estimated to be 
around 30–35%, ranging from 20 to 60%(7). The 
disparity of reported prevalence rates significantly 
depends on study methodology, diagnostic assessment 
tools, and time elapsed after stroke onset. Several 
established depression screening tools have been 
validated in stroke cohorts, and at least one tool has 
been developed specifically for depression screening in 
stroke survivors. The Zung and the PHQ-9, are designed 
to be both a screening tool and a diagnostic tool, where 
not just the overall score but the specific combination 
of symptoms are taken into consideration(8). Depression 
impedes rehabilitation progress following stroke and is 
associated with impaired functional outcome, cognitive 
decline, and increased mortality. Similarly, depression 
has been linked to increased risk of stroke occurrence. 
Despite high prevalence and serious sequels, PSD 
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INTRODUCTION
Stroke is the major cause of physical disability in adults, 
the second most common cause of dementia, and the 
third leading cause of death (after coronary-artery 
diseases and cancers).2 Vascular cognitive impairment 
is decline caused by ischemic, hemorrhagic, or oligemic 
injury to the brain as a consequence of cerebrovascular  
disease.It is one of the main causes of dependency in 
survivors and includes any dementia after a stroke, 
irrespective of its cause, which includes vascular, 
degenerative, or mixed. A huge increase in prevalence 
and burden of PSD is likely to happen because of the 
decline in mortality after stroke and ageing of 
populations.1 The 24 year study also indicated that 
prevalence of Post stroke Dementia associated with 
lacunar stroke was 7 times higher than other types of 
stroke, including Intracerebral hemorrhage6. According 
to Nys et al., a high proportion of stroke survivors 
developed the cognitive impairment within 3 months of 
stroke. In hospital-based studies, the prevalence of 
PSD ranges from 5•9 to 32%.3,4 In another study 
prevalence of PSD was 27.2%3. In community-based 
studies with adjustment for age, the prevalence of 
dementia in people with a history of stroke is about 
30%, which is 3.5–5.8- times higher than in those who 
have not had stroke.3,5  The 5-year survival rate is 39% 
for patients with vascular dementia compared with 75% 
for age-matched controls. Vascular dementia is 
associated with a higher mortality rate than AD, 
presumably because of the coexistence of other 
atherosclerotic diseases. Stroke is one of the main 
causes of disability in the population. PSD is further 
worsening quality of life of patients as well as other 
people and relatives living with them. The data 
regarding this problem is not available from Pakistan. 
The aim of this study will be to determine the burden of 
dementia in patients of stroke so intervention can be 
made to help peoples with PSD to cope with daily life.
OBJECTIVE OF STUDY
To find out frequency of vascular cognitive impairment 
in first ever ischemic stroke survivors, its severity and 3 
months outcome.
METHODOLOGY
Cross-sectional study at Department of Neurology CMC 
Hospital, SMBBMU Larkana from Aug-2014 to 
Jan-2015. Cases fulfilling the DSM-5 criteria were 
included in the study after informed consent: Evidence 
of cognitive decline from a previous level of perfor-
mance in one or more cognitive domains. 
B.   The clinical features consistent with a vascular
     etiology as suggested by either of the following: 
     1) Cognitive deficits is temporally related to one or 
     more cerebrovascular events; 
     2) Decline is prominent in complex attention and 
     frontal executive functions.
C.   There is evidence of the presence of cerebrovascular
     disease 
D.   The symptoms are not better explained by another 
     brain disease or systemic disorder.
Data was collected for age, sex, smoking status, 
education level, vascular risk factors, area of infarct, 
neuropsychological assessment and activity of daily 
living by AD8 scoring system. Both the in-patients and 
outpatient cases were included. Data was collected by 
researcher himself and analysis was done on SPSS 
version19. Patients of 30-60 years of age, of either 
gender, previously non demented with first episode of 
ischemic stroke confirmed by CT/MRI were included 
after informed consent. While cases of Hemorrhagic  
stroke, old stroke, known cases of  Parkinson’s disease, 
neurodegenerative disorders( AD,LBD,FTD) or Terminal 
cancers were excluded from the study. All patients were 
put on stroke protocol and their medical history, 
neuropsychological assessment, activity of daily living, a 
blood screen ,cardiac screen, and  vascular involvment 
of the stroke were recorded.
RESULTS
Total 120 patients were included in the study during 6 
month period with mean age of 52(±3.4) years. Among 
them 74(61.6%) were males and 46(38.3%) were 
females.
There were 48(40%) of patients in  age range of 41-50 
years group and 40(33.3%) In 51-60 yand 32(26.6%) 
in 31-40 Years of age.
There were n=50(41.66% ) patients in matriculated group 
while n=49(41%) were graduate and n=21(17.5%) in 
uneducated group. 
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remains undetected and untreated(6). So we planned 
this study to find the magnitude and related factors of 
PSD in survivors of stroke. Early diagnosis and successful 
intervention may improve clinical outcome of PSD and 
should be considered a key for better stroke care. Early 
effective treatment of depression may have a positive 
effect not only on depressive symptoms but also on the 
rehabilitation outcome of stroke patients.
Table-1
Distribution of Post stroke depression by gender
(n=100)
Table-2
Distribution of patients according to Depression 
Level
MATERIAL & METHODS
After approval from hospital ethical review board, this 
study was planned. It was a cross-sectional survey 
conducted at department of neurology, Services 
Institute of Medical Sciences (SIMS), Services hospital, 
Lahore over a period of one year, from January, 2014 to 
December, 2014. A sample size of 100 cases was 
calculated with 95% confidence level, 9.5% margin of 
error and taking expected percentage of depression i.e. 
34% after 1 month in post stroke patient(7). All the 
patients with stroke (confirmed by CT scan) presenting 
in out patient department, minimum after one month of 
the event, above 40 years of age were included in the 
study. Those having subarachnoid hemorrhage and 
venous etiology of stroke on CT scan brain, having 
history of death of spouse within 6 month duration and 
previous history of stroke were excluded from the study 
as all these factors are proven as isolated risk factors in 
different studies. These patients were evaluated for 
presence or absence of depression by researcher 
himself. A questionnaire was used as a data collection 
tool and score was given using Personal Health 
Questionnaire (PHQ-9) on the basis of diagnostic and 
statistical manual fourth version (DSM-iv). The rating 
scale was shown in questionnaire incorporated in 
performa with interpretation of total score as less than 
4 as no PSD, 5-9 asmild PSD, 10-14 as moderate 
PSD, 15-19 as moderately sever PSD and 20-27 as 
sever PSD. Also age, gender, side of the brain involved 
(dominant or non-dominant) and educational status of 
the patients were evaluated. All the collected data was 
entered into SPSS (statistical package for social 
sciences) 21.0 version and was analyzed descriptively. 
In our descriptive analysis, counts and percentages 
were calculated for qualitative variables like gender, PSD 
while mean and standard deviation were calculated for 
quantitative variables like patient age etc.
RESULTS
The mean age of patients was found to be 54.8 ± 8.1 
years in our study. Out of the total 100 patients, 33 
patients (33%) were in 40-50 year age group, 46 
patients (46%) were in 51-60 years age group and the 
remaining 21 patients (21 %) were in 60 years and 
above age group.Among 100 patients, 37% (n=37) 
were male and 63% (n=63) were female. In our study 
PSD was found in 35% (n=35) of the patients. Among 
these 35 patients with PSD 23 patients (65.7%) were 
female and 12 patients (34.3%) were male. Out of total 
of 63 female patients included, PSD was present in 23 
patients (36.5%) and was absent in the remaining 40 
patients (63.5%). As far as the male patients are 
concerned, out of the total 37 patients, PSD was 
present in 12 patients (32.4%) and absent in the 
remaining 25 patients (67.6%). Mild depression was 
present in 3 female patients but no male patient was 
found with mild depression in this study. Moderate 
depression was present in 4 male and 5 female 
patients. Moderately severe depression was observed in 
3 male and 5 female patients. Severe depression was 
observed in 5 male and 10 female patients. The average 
post stroke duration was 1.97±0.8 months in patients 
with PSD while it was 2.26±1.1 months in patients 
without PSD. In 22 patients (62.8%), lesion was on the 
left side of the brain (dominant half) and 13 patients 
(37.14%) had lesion on the right side of the brain 
(non-dominant half). There were 67 (67%) illiterates, 16 
(16%) educated up to primary school, 5 (5%) educated 
up to middle school and 8 (8%) educated high school 
and above of the total 100 patients.
DISCUSSION
Stroke is a disease associated with many complications. 
PSD is one of the important complications during 
post-stroke period. Although it is an important research 
issue and lot of work is being done on this subject in 
world but a little data is available on this subject in 
Pakistan (9). In this study we found that amongst the 
patients selected for the study, 37% were male and 
63% were females. It is in accordance with the results 
presented by most of the previous authors. ZhangWN 
and colleagues also found female gender as a risk 
factor. They calculated Odds Ratio (OR) value being 
3.1483, P<0.05 (10). It may be due to the factor that 
depression and psychological disorders are also 
otherwise more common in females than males. In our 
study we found the PSD in 35% of the patients. The 
reported frequency of PSD in previous studies ranges 
from 20% to 65% (11). This wide variation in results is 
due to different criteria for patient selection, some 
earlier studies are concerned with depression after 
ischemic stroke only or both ischemic and hemorrhagic 
stroke(12). The results also depend on the time elapsed 
after stroke and difficulties in estimating depression in 
stroke patients with a cognitive or physical handicap 
also cause inaccuracies(13). Although there was 
considerable variation in the reported frequency of 
depression after stroke across individual studies. A 
meta-analysis has estimated the pooled frequency of 
PSD at 33%, even with relevant differences across 
studies(14). PSD is commonly unrecognized and 
untreated in clinical practice. According to Schubert et 
al, nonpsychiatric physicians fail to diagnose 50% to 
80% of the actually existing depression. However, PSD 
is most likely not solely a psychological reflection of a 
physical disability(15). Folstein MF and colleagues 
conducted a trial and demonstrated that stroke patients 
were significantly more commonly depressed than 
orthopedic patients with equal levels of functional 
disability (45% versus 10%) (16). In our study also we 
found that 62.8% of patients with PSD had left 
hemisphere involvement than 37.2% having right side 
involved. Our findings are consistent with findings of 
Saxena A and Suman A, who found the PSD in 68.8% 
of patients with left hemisphere involvement than 
42.9% of patients with right side involved (P=0.008) 
(17). However, Wei N and colleagues recently published 
their systematic review on this topic and they found no 
correlation between PSD and side of brain involved. 
They only found significant association between non 
dominant hemisphere stroke and incidence of 
depression for studies within sub acute post-stroke 
phase. Due to this discrepancy in literature, this 
hypothesis that lesion of the dominant hemisphere are 
associated with an increased risk of depression after 
stroke, is no longer considered true (18). The mean age of 
patients found in our study was 54.8 ± 8.1 years. In 
our study this age was higher than previous studies 
because we included patients above age of 40 years 
because in our society particularly, male members are 
bread earners and disability at younger age is found 
having more depression than older ones (19). However, 
Naess presented their report on 196 patients with 
stroke and they found that stroke patients in age group 
15–49 had lower PSD incidence than elderly patients 
(20). But some data suggest that there was no significant 
differences between various age groups (21). The conflict 
conclusion may be drawn because different group of 
patients were chosen to be studied in different centers. 
So a large study sample with multi-center involvement 
must be conducted to sort this out. Also, there is a 
great variability in the method applied and the 
diagnostic tools used for the detection of PSD. Some 
researchers used structured statements or questions 
and other follow a structured interview and the 
diagnostic standards defined by DSM (Diagnostic and 
statistical manual of mental disorders)-III, III-R, and IV, 
and some even base their assessment only on clinical 
findings. Even when most of the studies based on the 
same diagnostic tool, the diagnosis on cutoff score 
varies in different rating scales. The PHQ-9 is a brief 
diagnostic and severity measure of depression, which 
has been widely used in research and clinical 
practice(22). The PHQ-9 was successfully used for 
screening post-stroke depression patients in our study. 
Similar findings are noted in the Heart and Soul study of 
depression among patients with coronary heart 
disease(23). A meta-analysis that included chronic care 
conditions involving patients from cardiology, renal 
dialyses, brain injury and stroke facilities as well as 
general medical out patients found the PHQ-9 
acceptable as a diagnostic screening tool for major 
depression(24). In spite of the abundant literature 
available on this topic, it is still difficult to define the real 
prevalence rate of PSD, essentially because of the 
weak concordance across studies. This relevant 
variability arises not only from methodological problems 
of the investigations (differences in study populations 
and the timing of assessments) but also from the 
complexity in recognition, assessment, and diagnosis of 
depression. In our study, there were 35 patients who 
were found to have PSD and these patients were 
referred to psychiatrist for treatment. It is recommended 
for all stroke patients to be evaluated for depression and 
must be treated accordingly to reduce the morbidity, 
mortality and to improve the functional outcome of the 
patients. 
CONCLUSIONS
Post stroke depression is common in patients with 
stroke and it directly or indirectly affects both morbidity 
and mortality in these patients. So in order to improve 
outcome in these patients, all patients with stroke 
should be screened and evaluated accordingly.
INTRODUCTION
Stroke is a common neurological problem and the third 
leading cause of death in developed countries of the 
world.(1) According to a survey in 2010, about 11.5 
million patients suffered from ischemic strokes (63% in 
low-income and middle-income countries) and 5.3 
million patients had hemorrhagic strokes (80% in 
low-income and middle-income countries). An 
estimated 5.8 million individuals died from stroke in a 
year(2). Among survivors, over 50% have significant 
disabilities creating physical, social and psychological 
burden on themselves as well as on the family(3). 
Neuropsychological symptoms are probably among the 
most commonly ignored complications in stroke 
patients. Depression is a common yet often 
unrecognized neuropsychological consequence of 
stroke, having biological, psycho behavioral and social 
dimensions(4). Post stroke depression (PSD) is 
multifactorial in origin and develops under the influence 
of biopsychosocial factors. The anatomical correlates of 
PSD change over time. The most relevant psychosocial 
risk factors for PSD may include: past history of 
depression and other mental disorders, dysphasia, 
functional impairment, lone living style, post-stroke 
social isolation & lack of family support(5). PSD is 
prevalent in both genders, but appears to be slightly 
more common among women than men. The reported 
prevalence of depression following a stroke varies from 
20% to 50% within the first year, with an apparent peak 
within the first 6 months of onset of event(6). According 
to another study, prevalence has been estimated to be 
around 30–35%, ranging from 20 to 60%(7). The 
disparity of reported prevalence rates significantly 
depends on study methodology, diagnostic assessment 
tools, and time elapsed after stroke onset. Several 
established depression screening tools have been 
validated in stroke cohorts, and at least one tool has 
been developed specifically for depression screening in 
stroke survivors. The Zung and the PHQ-9, are designed 
to be both a screening tool and a diagnostic tool, where 
not just the overall score but the specific combination 
of symptoms are taken into consideration(8). Depression 
impedes rehabilitation progress following stroke and is 
associated with impaired functional outcome, cognitive 
decline, and increased mortality. Similarly, depression 
has been linked to increased risk of stroke occurrence. 
Despite high prevalence and serious sequels, PSD 
PSD Male  Female
 Number % Number %
Yes 12 32.4 23 36.5
No 25 67.6 40 63.5
Total 37 100.0 63 100.0
Depression Level Male Female Total
NO DEPRESSION 25 40 65
MILD  0 3 3
MODERATE 4 5 9
MODERATELY SEVERE 3 5 8
SEVERE  5 10 15
INTRODUCTION
Stroke is the major cause of physical disability in adults, 
the second most common cause of dementia, and the 
third leading cause of death (after coronary-artery 
diseases and cancers).2 Vascular cognitive impairment 
is decline caused by ischemic, hemorrhagic, or oligemic 
injury to the brain as a consequence of cerebrovascular  
disease.It is one of the main causes of dependency in 
survivors and includes any dementia after a stroke, 
irrespective of its cause, which includes vascular, 
degenerative, or mixed. A huge increase in prevalence 
and burden of PSD is likely to happen because of the 
decline in mortality after stroke and ageing of 
populations.1 The 24 year study also indicated that 
prevalence of Post stroke Dementia associated with 
lacunar stroke was 7 times higher than other types of 
stroke, including Intracerebral hemorrhage6. According 
to Nys et al., a high proportion of stroke survivors 
developed the cognitive impairment within 3 months of 
stroke. In hospital-based studies, the prevalence of 
PSD ranges from 5•9 to 32%.3,4 In another study 
prevalence of PSD was 27.2%3. In community-based 
studies with adjustment for age, the prevalence of 
dementia in people with a history of stroke is about 
30%, which is 3.5–5.8- times higher than in those who 
have not had stroke.3,5  The 5-year survival rate is 39% 
for patients with vascular dementia compared with 75% 
for age-matched controls. Vascular dementia is 
associated with a higher mortality rate than AD, 
presumably because of the coexistence of other 
atherosclerotic diseases. Stroke is one of the main 
causes of disability in the population. PSD is further 
worsening quality of life of patients as well as other 
people and relatives living with them. The data 
regarding this problem is not available from Pakistan. 
The aim of this study will be to determine the burden of 
dementia in patients of stroke so intervention can be 
made to help peoples with PSD to cope with daily life.
OBJECTIVE OF STUDY
To find out frequency of vascular cognitive impairment 
in first ever ischemic stroke survivors, its severity and 3 
months outcome.
METHODOLOGY
Cross-sectional study at Department of Neurology CMC 
Hospital, SMBBMU Larkana from Aug-2014 to 
Jan-2015. Cases fulfilling the DSM-5 criteria were 
included in the study after informed consent: Evidence 
of cognitive decline from a previous level of perfor-
mance in one or more cognitive domains. 
B.   The clinical features consistent with a vascular
     etiology as suggested by either of the following: 
     1) Cognitive deficits is temporally related to one or 
     more cerebrovascular events; 
     2) Decline is prominent in complex attention and 
     frontal executive functions.
C.   There is evidence of the presence of cerebrovascular
     disease 
D.   The symptoms are not better explained by another 
     brain disease or systemic disorder.
Data was collected for age, sex, smoking status, 
education level, vascular risk factors, area of infarct, 
neuropsychological assessment and activity of daily 
living by AD8 scoring system. Both the in-patients and 
outpatient cases were included. Data was collected by 
researcher himself and analysis was done on SPSS 
version19. Patients of 30-60 years of age, of either 
gender, previously non demented with first episode of 
ischemic stroke confirmed by CT/MRI were included 
after informed consent. While cases of Hemorrhagic  
stroke, old stroke, known cases of  Parkinson’s disease, 
neurodegenerative disorders( AD,LBD,FTD) or Terminal 
cancers were excluded from the study. All patients were 
put on stroke protocol and their medical history, 
neuropsychological assessment, activity of daily living, a 
blood screen ,cardiac screen, and  vascular involvment 
of the stroke were recorded.
RESULTS
Total 120 patients were included in the study during 6 
month period with mean age of 52(±3.4) years. Among 
them 74(61.6%) were males and 46(38.3%) were 
females.
There were 48(40%) of patients in  age range of 41-50 
years group and 40(33.3%) In 51-60 yand 32(26.6%) 
in 31-40 Years of age.
There were n=50(41.66% ) patients in matriculated group 
while n=49(41%) were graduate and n=21(17.5%) in 
uneducated group. 
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remains undetected and untreated(6). So we planned 
this study to find the magnitude and related factors of 
PSD in survivors of stroke. Early diagnosis and successful 
intervention may improve clinical outcome of PSD and 
should be considered a key for better stroke care. Early 
effective treatment of depression may have a positive 
effect not only on depressive symptoms but also on the 
rehabilitation outcome of stroke patients.
Table-1
Distribution of Post stroke depression by gender
(n=100)
Table-2
Distribution of patients according to Depression 
Level
MATERIAL & METHODS
After approval from hospital ethical review board, this 
study was planned. It was a cross-sectional survey 
conducted at department of neurology, Services 
Institute of Medical Sciences (SIMS), Services hospital, 
Lahore over a period of one year, from January, 2014 to 
December, 2014. A sample size of 100 cases was 
calculated with 95% confidence level, 9.5% margin of 
error and taking expected percentage of depression i.e. 
34% after 1 month in post stroke patient(7). All the 
patients with stroke (confirmed by CT scan) presenting 
in out patient department, minimum after one month of 
the event, above 40 years of age were included in the 
study. Those having subarachnoid hemorrhage and 
venous etiology of stroke on CT scan brain, having 
history of death of spouse within 6 month duration and 
previous history of stroke were excluded from the study 
as all these factors are proven as isolated risk factors in 
different studies. These patients were evaluated for 
presence or absence of depression by researcher 
himself. A questionnaire was used as a data collection 
tool and score was given using Personal Health 
Questionnaire (PHQ-9) on the basis of diagnostic and 
statistical manual fourth version (DSM-iv). The rating 
scale was shown in questionnaire incorporated in 
performa with interpretation of total score as less than 
4 as no PSD, 5-9 asmild PSD, 10-14 as moderate 
PSD, 15-19 as moderately sever PSD and 20-27 as 
sever PSD. Also age, gender, side of the brain involved 
(dominant or non-dominant) and educational status of 
the patients were evaluated. All the collected data was 
entered into SPSS (statistical package for social 
sciences) 21.0 version and was analyzed descriptively. 
In our descriptive analysis, counts and percentages 
were calculated for qualitative variables like gender, PSD 
while mean and standard deviation were calculated for 
quantitative variables like patient age etc.
RESULTS
The mean age of patients was found to be 54.8 ± 8.1 
years in our study. Out of the total 100 patients, 33 
patients (33%) were in 40-50 year age group, 46 
patients (46%) were in 51-60 years age group and the 
remaining 21 patients (21 %) were in 60 years and 
above age group.Among 100 patients, 37% (n=37) 
were male and 63% (n=63) were female. In our study 
PSD was found in 35% (n=35) of the patients. Among 
these 35 patients with PSD 23 patients (65.7%) were 
female and 12 patients (34.3%) were male. Out of total 
of 63 female patients included, PSD was present in 23 
patients (36.5%) and was absent in the remaining 40 
patients (63.5%). As far as the male patients are 
concerned, out of the total 37 patients, PSD was 
present in 12 patients (32.4%) and absent in the 
remaining 25 patients (67.6%). Mild depression was 
present in 3 female patients but no male patient was 
found with mild depression in this study. Moderate 
depression was present in 4 male and 5 female 
patients. Moderately severe depression was observed in 
3 male and 5 female patients. Severe depression was 
observed in 5 male and 10 female patients. The average 
post stroke duration was 1.97±0.8 months in patients 
with PSD while it was 2.26±1.1 months in patients 
without PSD. In 22 patients (62.8%), lesion was on the 
left side of the brain (dominant half) and 13 patients 
(37.14%) had lesion on the right side of the brain 
(non-dominant half). There were 67 (67%) illiterates, 16 
(16%) educated up to primary school, 5 (5%) educated 
up to middle school and 8 (8%) educated high school 
and above of the total 100 patients.
DISCUSSION
Stroke is a disease associated with many complications. 
PSD is one of the important complications during 
post-stroke period. Although it is an important research 
issue and lot of work is being done on this subject in 
world but a little data is available on this subject in 
Pakistan (9). In this study we found that amongst the 
patients selected for the study, 37% were male and 
63% were females. It is in accordance with the results 
presented by most of the previous authors. ZhangWN 
and colleagues also found female gender as a risk 
factor. They calculated Odds Ratio (OR) value being 
3.1483, P<0.05 (10). It may be due to the factor that 
depression and psychological disorders are also 
otherwise more common in females than males. In our 
study we found the PSD in 35% of the patients. The 
reported frequency of PSD in previous studies ranges 
from 20% to 65% (11). This wide variation in results is 
due to different criteria for patient selection, some 
earlier studies are concerned with depression after 
ischemic stroke only or both ischemic and hemorrhagic 
stroke(12). The results also depend on the time elapsed 
after stroke and difficulties in estimating depression in 
stroke patients with a cognitive or physical handicap 
also cause inaccuracies(13). Although there was 
considerable variation in the reported frequency of 
depression after stroke across individual studies. A 
meta-analysis has estimated the pooled frequency of 
PSD at 33%, even with relevant differences across 
studies(14). PSD is commonly unrecognized and 
untreated in clinical practice. According to Schubert et 
al, nonpsychiatric physicians fail to diagnose 50% to 
80% of the actually existing depression. However, PSD 
is most likely not solely a psychological reflection of a 
physical disability(15). Folstein MF and colleagues 
conducted a trial and demonstrated that stroke patients 
were significantly more commonly depressed than 
orthopedic patients with equal levels of functional 
disability (45% versus 10%) (16). In our study also we 
found that 62.8% of patients with PSD had left 
hemisphere involvement than 37.2% having right side 
involved. Our findings are consistent with findings of 
Saxena A and Suman A, who found the PSD in 68.8% 
of patients with left hemisphere involvement than 
42.9% of patients with right side involved (P=0.008) 
(17). However, Wei N and colleagues recently published 
their systematic review on this topic and they found no 
correlation between PSD and side of brain involved. 
They only found significant association between non 
dominant hemisphere stroke and incidence of 
depression for studies within sub acute post-stroke 
phase. Due to this discrepancy in literature, this 
hypothesis that lesion of the dominant hemisphere are 
associated with an increased risk of depression after 
stroke, is no longer considered true (18). The mean age of 
patients found in our study was 54.8 ± 8.1 years. In 
our study this age was higher than previous studies 
because we included patients above age of 40 years 
because in our society particularly, male members are 
bread earners and disability at younger age is found 
having more depression than older ones (19). However, 
Naess presented their report on 196 patients with 
stroke and they found that stroke patients in age group 
15–49 had lower PSD incidence than elderly patients 
(20). But some data suggest that there was no significant 
differences between various age groups (21). The conflict 
conclusion may be drawn because different group of 
patients were chosen to be studied in different centers. 
So a large study sample with multi-center involvement 
must be conducted to sort this out. Also, there is a 
great variability in the method applied and the 
diagnostic tools used for the detection of PSD. Some 
researchers used structured statements or questions 
and other follow a structured interview and the 
diagnostic standards defined by DSM (Diagnostic and 
statistical manual of mental disorders)-III, III-R, and IV, 
and some even base their assessment only on clinical 
findings. Even when most of the studies based on the 
same diagnostic tool, the diagnosis on cutoff score 
varies in different rating scales. The PHQ-9 is a brief 
diagnostic and severity measure of depression, which 
has been widely used in research and clinical 
practice(22). The PHQ-9 was successfully used for 
screening post-stroke depression patients in our study. 
Similar findings are noted in the Heart and Soul study of 
depression among patients with coronary heart 
disease(23). A meta-analysis that included chronic care 
conditions involving patients from cardiology, renal 
dialyses, brain injury and stroke facilities as well as 
general medical out patients found the PHQ-9 
acceptable as a diagnostic screening tool for major 
depression(24). In spite of the abundant literature 
available on this topic, it is still difficult to define the real 
prevalence rate of PSD, essentially because of the 
weak concordance across studies. This relevant 
variability arises not only from methodological problems 
of the investigations (differences in study populations 
and the timing of assessments) but also from the 
complexity in recognition, assessment, and diagnosis of 
depression. In our study, there were 35 patients who 
were found to have PSD and these patients were 
referred to psychiatrist for treatment. It is recommended 
for all stroke patients to be evaluated for depression and 
must be treated accordingly to reduce the morbidity, 
mortality and to improve the functional outcome of the 
patients. 
CONCLUSIONS
Post stroke depression is common in patients with 
stroke and it directly or indirectly affects both morbidity 
and mortality in these patients. So in order to improve 
outcome in these patients, all patients with stroke 
should be screened and evaluated accordingly.
INTRODUCTION
Stroke is a common neurological problem and the third 
leading cause of death in developed countries of the 
world.(1) According to a survey in 2010, about 11.5 
million patients suffered from ischemic strokes (63% in 
low-income and middle-income countries) and 5.3 
million patients had hemorrhagic strokes (80% in 
low-income and middle-income countries). An 
estimated 5.8 million individuals died from stroke in a 
year(2). Among survivors, over 50% have significant 
disabilities creating physical, social and psychological 
burden on themselves as well as on the family(3). 
Neuropsychological symptoms are probably among the 
most commonly ignored complications in stroke 
patients. Depression is a common yet often 
unrecognized neuropsychological consequence of 
stroke, having biological, psycho behavioral and social 
dimensions(4). Post stroke depression (PSD) is 
multifactorial in origin and develops under the influence 
of biopsychosocial factors. The anatomical correlates of 
PSD change over time. The most relevant psychosocial 
risk factors for PSD may include: past history of 
depression and other mental disorders, dysphasia, 
functional impairment, lone living style, post-stroke 
social isolation & lack of family support(5). PSD is 
prevalent in both genders, but appears to be slightly 
more common among women than men. The reported 
prevalence of depression following a stroke varies from 
20% to 50% within the first year, with an apparent peak 
within the first 6 months of onset of event(6). According 
to another study, prevalence has been estimated to be 
around 30–35%, ranging from 20 to 60%(7). The 
disparity of reported prevalence rates significantly 
depends on study methodology, diagnostic assessment 
tools, and time elapsed after stroke onset. Several 
established depression screening tools have been 
validated in stroke cohorts, and at least one tool has 
been developed specifically for depression screening in 
stroke survivors. The Zung and the PHQ-9, are designed 
to be both a screening tool and a diagnostic tool, where 
not just the overall score but the specific combination 
of symptoms are taken into consideration(8). Depression 
impedes rehabilitation progress following stroke and is 
associated with impaired functional outcome, cognitive 
decline, and increased mortality. Similarly, depression 
has been linked to increased risk of stroke occurrence. 
Despite high prevalence and serious sequels, PSD 
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injury to the brain as a consequence of cerebrovascular  
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irrespective of its cause, which includes vascular, 
degenerative, or mixed. A huge increase in prevalence 
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decline in mortality after stroke and ageing of 
populations.1 The 24 year study also indicated that 
prevalence of Post stroke Dementia associated with 
lacunar stroke was 7 times higher than other types of 
stroke, including Intracerebral hemorrhage6. According 
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for age-matched controls. Vascular dementia is 
associated with a higher mortality rate than AD, 
presumably because of the coexistence of other 
atherosclerotic diseases. Stroke is one of the main 
causes of disability in the population. PSD is further 
worsening quality of life of patients as well as other 
people and relatives living with them. The data 
regarding this problem is not available from Pakistan. 
The aim of this study will be to determine the burden of 
dementia in patients of stroke so intervention can be 
made to help peoples with PSD to cope with daily life.
OBJECTIVE OF STUDY
To find out frequency of vascular cognitive impairment 
in first ever ischemic stroke survivors, its severity and 3 
months outcome.
METHODOLOGY
Cross-sectional study at Department of Neurology CMC 
Hospital, SMBBMU Larkana from Aug-2014 to 
Jan-2015. Cases fulfilling the DSM-5 criteria were 
included in the study after informed consent: Evidence 
of cognitive decline from a previous level of perfor-
mance in one or more cognitive domains. 
B.   The clinical features consistent with a vascular
     etiology as suggested by either of the following: 
     1) Cognitive deficits is temporally related to one or 
     more cerebrovascular events; 
     2) Decline is prominent in complex attention and 
     frontal executive functions.
C.   There is evidence of the presence of cerebrovascular
     disease 
D.   The symptoms are not better explained by another 
     brain disease or systemic disorder.
Data was collected for age, sex, smoking status, 
education level, vascular risk factors, area of infarct, 
neuropsychological assessment and activity of daily 
living by AD8 scoring system. Both the in-patients and 
outpatient cases were included. Data was collected by 
researcher himself and analysis was done on SPSS 
version19. Patients of 30-60 years of age, of either 
gender, previously non demented with first episode of 
ischemic stroke confirmed by CT/MRI were included 
after informed consent. While cases of Hemorrhagic  
stroke, old stroke, known cases of  Parkinson’s disease, 
neurodegenerative disorders( AD,LBD,FTD) or Terminal 
cancers were excluded from the study. All patients were 
put on stroke protocol and their medical history, 
neuropsychological assessment, activity of daily living, a 
blood screen ,cardiac screen, and  vascular involvment 
of the stroke were recorded.
RESULTS
Total 120 patients were included in the study during 6 
month period with mean age of 52(±3.4) years. Among 
them 74(61.6%) were males and 46(38.3%) were 
females.
There were 48(40%) of patients in  age range of 41-50 
years group and 40(33.3%) In 51-60 yand 32(26.6%) 
in 31-40 Years of age.
There were n=50(41.66% ) patients in matriculated group 
while n=49(41%) were graduate and n=21(17.5%) in 
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remains undetected and untreated(6). So we planned 
this study to find the magnitude and related factors of 
PSD in survivors of stroke. Early diagnosis and successful 
intervention may improve clinical outcome of PSD and 
should be considered a key for better stroke care. Early 
effective treatment of depression may have a positive 
effect not only on depressive symptoms but also on the 
rehabilitation outcome of stroke patients.
Table-1
Distribution of Post stroke depression by gender
(n=100)
Table-2
Distribution of patients according to Depression 
Level
MATERIAL & METHODS
After approval from hospital ethical review board, this 
study was planned. It was a cross-sectional survey 
conducted at department of neurology, Services 
Institute of Medical Sciences (SIMS), Services hospital, 
Lahore over a period of one year, from January, 2014 to 
December, 2014. A sample size of 100 cases was 
calculated with 95% confidence level, 9.5% margin of 
error and taking expected percentage of depression i.e. 
34% after 1 month in post stroke patient(7). All the 
patients with stroke (confirmed by CT scan) presenting 
in out patient department, minimum after one month of 
the event, above 40 years of age were included in the 
study. Those having subarachnoid hemorrhage and 
venous etiology of stroke on CT scan brain, having 
history of death of spouse within 6 month duration and 
previous history of stroke were excluded from the study 
as all these factors are proven as isolated risk factors in 
different studies. These patients were evaluated for 
presence or absence of depression by researcher 
himself. A questionnaire was used as a data collection 
tool and score was given using Personal Health 
Questionnaire (PHQ-9) on the basis of diagnostic and 
statistical manual fourth version (DSM-iv). The rating 
scale was shown in questionnaire incorporated in 
performa with interpretation of total score as less than 
4 as no PSD, 5-9 asmild PSD, 10-14 as moderate 
PSD, 15-19 as moderately sever PSD and 20-27 as 
sever PSD. Also age, gender, side of the brain involved 
(dominant or non-dominant) and educational status of 
the patients were evaluated. All the collected data was 
entered into SPSS (statistical package for social 
sciences) 21.0 version and was analyzed descriptively. 
In our descriptive analysis, counts and percentages 
were calculated for qualitative variables like gender, PSD 
while mean and standard deviation were calculated for 
quantitative variables like patient age etc.
RESULTS
The mean age of patients was found to be 54.8 ± 8.1 
years in our study. Out of the total 100 patients, 33 
patients (33%) were in 40-50 year age group, 46 
patients (46%) were in 51-60 years age group and the 
remaining 21 patients (21 %) were in 60 years and 
above age group.Among 100 patients, 37% (n=37) 
were male and 63% (n=63) were female. In our study 
PSD was found in 35% (n=35) of the patients. Among 
these 35 patients with PSD 23 patients (65.7%) were 
female and 12 patients (34.3%) were male. Out of total 
of 63 female patients included, PSD was present in 23 
patients (36.5%) and was absent in the remaining 40 
patients (63.5%). As far as the male patients are 
concerned, out of the total 37 patients, PSD was 
present in 12 patients (32.4%) and absent in the 
remaining 25 patients (67.6%). Mild depression was 
present in 3 female patients but no male patient was 
found with mild depression in this study. Moderate 
depression was present in 4 male and 5 female 
patients. Moderately severe depression was observed in 
3 male and 5 female patients. Severe depression was 
observed in 5 male and 10 female patients. The average 
post stroke duration was 1.97±0.8 months in patients 
with PSD while it was 2.26±1.1 months in patients 
without PSD. In 22 patients (62.8%), lesion was on the 
left side of the brain (dominant half) and 13 patients 
(37.14%) had lesion on the right side of the brain 
(non-dominant half). There were 67 (67%) illiterates, 16 
(16%) educated up to primary school, 5 (5%) educated 
up to middle school and 8 (8%) educated high school 
and above of the total 100 patients.
DISCUSSION
Stroke is a disease associated with many complications. 
PSD is one of the important complications during 
post-stroke period. Although it is an important research 
issue and lot of work is being done on this subject in 
world but a little data is available on this subject in 
Pakistan (9). In this study we found that amongst the 
patients selected for the study, 37% were male and 
63% were females. It is in accordance with the results 
presented by most of the previous authors. ZhangWN 
and colleagues also found female gender as a risk 
factor. They calculated Odds Ratio (OR) value being 
3.1483, P<0.05 (10). It may be due to the factor that 
depression and psychological disorders are also 
otherwise more common in females than males. In our 
study we found the PSD in 35% of the patients. The 
reported frequency of PSD in previous studies ranges 
from 20% to 65% (11). This wide variation in results is 
due to different criteria for patient selection, some 
earlier studies are concerned with depression after 
ischemic stroke only or both ischemic and hemorrhagic 
stroke(12). The results also depend on the time elapsed 
after stroke and difficulties in estimating depression in 
stroke patients with a cognitive or physical handicap 
also cause inaccuracies(13). Although there was 
considerable variation in the reported frequency of 
depression after stroke across individual studies. A 
meta-analysis has estimated the pooled frequency of 
PSD at 33%, even with relevant differences across 
studies(14). PSD is commonly unrecognized and 
untreated in clinical practice. According to Schubert et 
al, nonpsychiatric physicians fail to diagnose 50% to 
80% of the actually existing depression. However, PSD 
is most likely not solely a psychological reflection of a 
physical disability(15). Folstein MF and colleagues 
conducted a trial and demonstrated that stroke patients 
were significantly more commonly depressed than 
orthopedic patients with equal levels of functional 
disability (45% versus 10%) (16). In our study also we 
found that 62.8% of patients with PSD had left 
hemisphere involvement than 37.2% having right side 
involved. Our findings are consistent with findings of 
Saxena A and Suman A, who found the PSD in 68.8% 
of patients with left hemisphere involvement than 
42.9% of patients with right side involved (P=0.008) 
(17). However, Wei N and colleagues recently published 
their systematic review on this topic and they found no 
correlation between PSD and side of brain involved. 
They only found significant association between non 
dominant hemisphere stroke and incidence of 
depression for studies within sub acute post-stroke 
phase. Due to this discrepancy in literature, this 
hypothesis that lesion of the dominant hemisphere are 
associated with an increased risk of depression after 
stroke, is no longer considered true (18). The mean age of 
patients found in our study was 54.8 ± 8.1 years. In 
our study this age was higher than previous studies 
because we included patients above age of 40 years 
because in our society particularly, male members are 
bread earners and disability at younger age is found 
having more depression than older ones (19). However, 
Naess presented their report on 196 patients with 
stroke and they found that stroke patients in age group 
15–49 had lower PSD incidence than elderly patients 
(20). But some data suggest that there was no significant 
differences between various age groups (21). The conflict 
conclusion may be drawn because different group of 
patients were chosen to be studied in different centers. 
So a large study sample with multi-center involvement 
must be conducted to sort this out. Also, there is a 
great variability in the method applied and the 
diagnostic tools used for the detection of PSD. Some 
researchers used structured statements or questions 
and other follow a structured interview and the 
diagnostic standards defined by DSM (Diagnostic and 
statistical manual of mental disorders)-III, III-R, and IV, 
and some even base their assessment only on clinical 
findings. Even when most of the studies based on the 
same diagnostic tool, the diagnosis on cutoff score 
varies in different rating scales. The PHQ-9 is a brief 
diagnostic and severity measure of depression, which 
has been widely used in research and clinical 
practice(22). The PHQ-9 was successfully used for 
screening post-stroke depression patients in our study. 
Similar findings are noted in the Heart and Soul study of 
depression among patients with coronary heart 
disease(23). A meta-analysis that included chronic care 
conditions involving patients from cardiology, renal 
dialyses, brain injury and stroke facilities as well as 
general medical out patients found the PHQ-9 
acceptable as a diagnostic screening tool for major 
depression(24). In spite of the abundant literature 
available on this topic, it is still difficult to define the real 
prevalence rate of PSD, essentially because of the 
weak concordance across studies. This relevant 
variability arises not only from methodological problems 
of the investigations (differences in study populations 
and the timing of assessments) but also from the 
complexity in recognition, assessment, and diagnosis of 
depression. In our study, there were 35 patients who 
were found to have PSD and these patients were 
referred to psychiatrist for treatment. It is recommended 
for all stroke patients to be evaluated for depression and 
must be treated accordingly to reduce the morbidity, 
mortality and to improve the functional outcome of the 
patients. 
CONCLUSIONS
Post stroke depression is common in patients with 
stroke and it directly or indirectly affects both morbidity 
and mortality in these patients. So in order to improve 
outcome in these patients, all patients with stroke 
should be screened and evaluated accordingly.
INTRODUCTION
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year(2). Among survivors, over 50% have significant 
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multifactorial in origin and develops under the influence 
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prevalent in both genders, but appears to be slightly 
more common among women than men. The reported 
prevalence of depression following a stroke varies from 
20% to 50% within the first year, with an apparent peak 
within the first 6 months of onset of event(6). According 
to another study, prevalence has been estimated to be 
around 30–35%, ranging from 20 to 60%(7). The 
disparity of reported prevalence rates significantly 
depends on study methodology, diagnostic assessment 
tools, and time elapsed after stroke onset. Several 
established depression screening tools have been 
validated in stroke cohorts, and at least one tool has 
been developed specifically for depression screening in 
stroke survivors. The Zung and the PHQ-9, are designed 
to be both a screening tool and a diagnostic tool, where 
not just the overall score but the specific combination 
of symptoms are taken into consideration(8). Depression 
impedes rehabilitation progress following stroke and is 
associated with impaired functional outcome, cognitive 
decline, and increased mortality. Similarly, depression 
has been linked to increased risk of stroke occurrence. 
Despite high prevalence and serious sequels, PSD 
INTRODUCTION
Stroke is the major cause of physical disability in adults, 
the second most common cause of dementia, and the 
third leading cause of death (after coronary-artery 
diseases and cancers).2 Vascular cognitive impairment 
is decline caused by ischemic, hemorrhagic, or oligemic 
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survivors and includes any dementia after a stroke, 
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degenerative, or mixed. A huge increase in prevalence 
and burden of PSD is likely to happen because of the 
decline in mortality after stroke and ageing of 
populations.1 The 24 year study also indicated that 
prevalence of Post stroke Dementia associated with 
lacunar stroke was 7 times higher than other types of 
stroke, including Intracerebral hemorrhage6. According 
to Nys et al., a high proportion of stroke survivors 
developed the cognitive impairment within 3 months of 
stroke. In hospital-based studies, the prevalence of 
PSD ranges from 5•9 to 32%.3,4 In another study 
prevalence of PSD was 27.2%3. In community-based 
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dementia in people with a history of stroke is about 
30%, which is 3.5–5.8- times higher than in those who 
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associated with a higher mortality rate than AD, 
presumably because of the coexistence of other 
atherosclerotic diseases. Stroke is one of the main 
causes of disability in the population. PSD is further 
worsening quality of life of patients as well as other 
people and relatives living with them. The data 
regarding this problem is not available from Pakistan. 
The aim of this study will be to determine the burden of 
dementia in patients of stroke so intervention can be 
made to help peoples with PSD to cope with daily life.
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in first ever ischemic stroke survivors, its severity and 3 
months outcome.
METHODOLOGY
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Hospital, SMBBMU Larkana from Aug-2014 to 
Jan-2015. Cases fulfilling the DSM-5 criteria were 
included in the study after informed consent: Evidence 
of cognitive decline from a previous level of perfor-
mance in one or more cognitive domains. 
B.   The clinical features consistent with a vascular
     etiology as suggested by either of the following: 
     1) Cognitive deficits is temporally related to one or 
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     2) Decline is prominent in complex attention and 
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D.   The symptoms are not better explained by another 
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Data was collected for age, sex, smoking status, 
education level, vascular risk factors, area of infarct, 
neuropsychological assessment and activity of daily 
living by AD8 scoring system. Both the in-patients and 
outpatient cases were included. Data was collected by 
researcher himself and analysis was done on SPSS 
version19. Patients of 30-60 years of age, of either 
gender, previously non demented with first episode of 
ischemic stroke confirmed by CT/MRI were included 
after informed consent. While cases of Hemorrhagic  
stroke, old stroke, known cases of  Parkinson’s disease, 
neurodegenerative disorders( AD,LBD,FTD) or Terminal 
cancers were excluded from the study. All patients were 
put on stroke protocol and their medical history, 
neuropsychological assessment, activity of daily living, a 
blood screen ,cardiac screen, and  vascular involvment 
of the stroke were recorded.
RESULTS
Total 120 patients were included in the study during 6 
month period with mean age of 52(±3.4) years. Among 
them 74(61.6%) were males and 46(38.3%) were 
females.
There were 48(40%) of patients in  age range of 41-50 
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in 31-40 Years of age.
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